Doxazosin Mesylate
Doxazosin, a quinazoline-derivative, selectively antagonizes postsynaptic α1-adrenergic receptors, used in the treatment of high blood pressure and urinary retention associated with benign prostatic hyperplasia.
Trivial name | N/A |
Catalog Number | S1324 |
Molecular Formula | C23H25N5O5.CH4O3S |
CAS# | 77883-43-3 |
Inchi | InChI=1S/C23H25N5O5.CH4O3S/c1-30-18-11-14-15(12-19(18)31-2)25-23(26-21(14)24)28-9-7-27(8-10-28)22(29)20-13-32-16-5-3-4-6-17(16)33-20;1-5(2,3)4/h3-6,11-12,20H,7-10,13H2,1-2H3,(H2,24,25,26);1H3,(H,2,3,4 ) |
Inchi Key | VJECBOKJABCYMF-UHFFFAOYSA-N |
SMILES | COC1=C(C=C2C(=C1)C(=NC(=N2)N3CCN(CC3)C(=O)C4COC5=CC=CC=C5O4)N)OC.CS(=O)(=O)O |
Size | 50mg |
Supplier Page | http://www.selleckchem.com/products/Doxazosin-mesylate.html |
Additional Information | https://file.selleck.cn/downloads/struct/Doxazosin-chemical-structure-S1324.gif |